Navigation Links
Prostate Conditions Education Council Opposes U.S. Preventative Services Task Force Recommendation
Date:10/10/2011

DENVER, Oct. 10, 2011 /PRNewswire-USNewswire/ -- The Prostate Conditions Education Council (PCEC) – a national organization committed to men's health and a leader in prostate cancer screening – today announced it strongly opposes the newly released recommendations from the U.S. Preventative Services Task Force (USPSTF). The draft guidance recommends against prostate-specific antigen (PSA) screening for prostate cancer.

PCEC believes that until a more accurate and reliable diagnostic tool exists, the Prostate-Specific Antigen (PSA) test and Digital Rectal Exam (DRE) remain the safest routes to detecting the disease in its earliest stages – when it's most treatable. The PSA test is one of the only tools men have to detect the second leading cause of cancer death among American men,(i) and the USPSTF recommendations could limit access and wide-spread screening.

"As an organization that helps screen thousands of men annually and more than five million in the last 22 years, we have an up-close perspective: listening to men's questions, educating them about the current screening tools and hearing about stories of survival," said Wendy Poage, president of the Prostate Conditions Education Council. "Mortality rates have decreased with the onset of PSA screening and we cannot slip back to an era where all men were diagnosed with advanced disease because no screening was available. While we applaud USPSTF for bringing this issue to a national discussion, we believe that the pendulum has moved too far and that corrections need to be made to help patients navigate this important public health issue."

PCEC's specific recommendations include:

Separating Diagnosis Issue From Treatment Decision Making

PCEC believes that the treatment decision making process should be the key area of focus for debate, not the issue of screening. Over-treatment of prostate conditions should be addressed through greater doctor-patient communication regarding appropriate diagnostic options and treatments to determine the right action based on the patient.

Increasing Access to Advanced Diagnostic Technology

New technologies including the Transperineal 3D Mapping Biopsy are allowing physicians to better understand the stage and gravity of the cancer in order to make more informed treatment decisions.  Experts agree that prostate staging biopsies will yield better understanding of the extent and aggressiveness of the disease in patients. This information allows physicians to develop individualized treatment plans for patients.  

Expedite U.S. Food and Drug Administration's Review of New Diagnostics

The FDA should encourage the development of new diagnostic and screening tools by expediting review of all promising prostate cancer diagnostic tests. The FDA is currently reviewing the Prostate Health Index which may provide additional context to patients risk for an aggressive form of cancer.

Encourage a Focus on Men's Overall Health

Many prostate screening locations also offer testing for cholesterol and testosterone, as many factors play into overall men's health awareness and a man's risk for prostate cancer.  PCEC screening sites are equipped with a variety of free informational materials that help guide men in improving their overall health condition.

About Prostate Conditions Education Council

A national organization committed to men's health, the Prostate Conditions Education Council (PCEC) is the nation's leading resource for information on prostate health.  The PCEC is dedicated to saving lives through awareness and the education of men, the women in their lives, as well as the medical community about prostate cancer prevalence, the importance of early detection, and available treatment options, as well as other men's health issues.  The Council – comprised of a consortium of leading physicians, health educators, scientists and prostate cancer advocates – aims to conduct nation wide screenings for men and perform research that will aid in the detection and treatment of prostate conditions.  More information is available at www.prostateconditions.org.  

REFERENCES:

(i)  http://www.cdc.gov/cancer/dcpc/data/men.htm


'/>"/>
SOURCE Prostate Conditions Education Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The US Oncology Network Affiliated Physicians at Forefront of Cutting-Edge Prostate Cancer Treatment
2. First Prostate Cancer Registry for Robotic Radiosurgery Patients Enrolls More than 500 Men
3. Robotic Surgery Frees Sliwa of Prostate Cancer
4. Prostate Cancer Treatment: Match Between CyberKnife And Robotic Prostate Surgery And The Winner Is?
5. FDA Approves New Indications for Prolia® (Denosumab) for the Treatment of Bone Loss in Patients With Prostate or Breast Cancer Undergoing Hormone Ablation Therapy
6. OncoGenex Announces Completion of a Special Protocol Assessment (SPA) Amendment with the FDA Increasing Patient Eligibility for the Custirsen Phase III Prostate Cancer SATURN Clinical Trial
7. Prostate Cancer Awareness Month Starts in September
8. Study Explores Utilization Trends for Prostate Cancer Treatments
9. Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer
10. FDA Grants Fast Track Designation to Bayers Investigational Compound Radium-223 Chloride for the Treatment of Castration-Resistant Prostate Cancer That Has Spread to the Bone
11. China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 23, 2017 Report analyzes the worldwide markets for ... analytics for the US, Canada , ... Asia-Pacific , Latin America , ... for the period 2015 through 2022. Also, a six-year historic ... are derived from primary and secondary research. Company profiles are ...
(Date:2/24/2017)... ITL Limited, ( ASX : ITD ), une société de ... excellents résultats semestriels clos le 31 décembre 2016 par ... « Résultats et mise à jour sur la croissance biomédicale ... Faits marquants Bénéfice ... hausse de 104 %) Bénéfice par action ...
(Date:2/24/2017)... -- This report analyzes the worldwide markets for Chiral Technology ... Products: Intermediates, Analytical, and Others. The End Use markets ... The report provides separate comprehensive analytics for the US, ... , and Rest of World. Annual estimates and forecasts ... a six-year historic analysis is provided for these markets. ...
Breaking Medicine Technology:
(Date:2/27/2017)... ... February 27, 2017 , ... POUGHKEEPSIE, N. Y. – Peer-reviewed guidelines ... despite scientific studies, the Center for Disease Control ( CDC ) and Infectious Diseases ... Kenneth B. Liegner, M.D. has compiled into a single volume a compelling argument that ...
(Date:2/27/2017)... Francisco, CA (PRWEB) , ... February 27, 2017 ... ... clinic serving San Francisco and environs, is proud to announce an upgrade to ... information on the upgraded Yelp page on topics as diverse as Platelet Rich ...
(Date:2/26/2017)... ... 2017 , ... This is an extension of airmid’s scope ... ISO/IEC 17025:2005 INAB accredited for Der p 1 (house dust mite allergen) & ... standard that sets out requirements for the technical competence of testing and calibration ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... technology standard in staffing, scheduling, and reporting for healthcare organizations. This comprehensive ... throughout the entire staffing process. StaffBridge technology improves staffing efficiency, maximizes resource ...
(Date:2/25/2017)... ... , ... FCPX users now have the ability to sharpen a desired color ... users have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, vertical sharpening, ... users can visually see the color range effected with ease all within Final ...
Breaking Medicine News(10 mins):